-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Antiviral agent 12
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/314030-54-12d.gif)
| Category | Filovirus |
| CAS | 314030-54-1 |
| Description | N-(1-Benzyl-4-piperidyl)adamantane-1-carboxamide inhibits Ebola virus entry into host cells by binding to surface glycoproteins, and it inhibits the Ebola virus with an EC50 of 3.9 μM. |
Product Information
| Synonyms | 314030-54-1;N-(1-benzylpiperidin-4-yl)adamantane-1-carboxamide;Antiviral agent 12;N-(1-benzyl-4-piperidyl)adamantane-1-carboxamide;Oprea1_394577;Oprea1_833933;CHEMBL1621026;SCHEMBL19172948;EX-A4094;AKOS000671998;PD158745;TS-09814;HY-115848;CS-0369318;Z68296869; |
| IUPAC Name | N-(1-benzylpiperidin-4-yl)adamantane-1-carboxamide |
| Molecular Weight | 186.67 |
| Molecular Formula | C6H15ClN2O2 |
| Canonical SMILES | [2H]C([2H])(C[C@@H](C(=O)O)N)C([2H])([2H])CN.Cl |
| InChI | InChI=1S/C23H32N2O/c26-22(23-13-18-10-19(14-23)12-20(11-18)15-23)24-21-6-8-25(9-7-21)16-17-4-2-1-3-5-17/h1-5,18-21H,6-16H2,(H,24,26) |
| InChIKey | DMJLKSCNJVAFLZ-UHFFFAOYSA-N |
| Boiling Point | 525.1±39.0°C at 760 mmHg |
| Purity | ≥95% |
| Density | 1.14±0.1 g/cm3 |
| Solubility | Soluble in DMSO |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
